Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Gabapentin NDC 50090-3318 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
1 - image 1
This text appears to be a formula used to estimate the glomerular filtration rate (GFR) in patients, which is a measure of the kidney function. The formula uses the patient's age and weight to calculate a value for cLcr, which is then multiplied by the serum creatinine level to estimate GFR. It is important to note that this is not a precise measure of kidney function and should only be used as a rough estimate.*
1 - image 2
1 - image 3
1 - image 4
1 - image 5
1 - image 6
The text is describing a graph or table with a Mean Pain Score of 10. The graph or table shows a Dose Tiration Period that lasts for 4 weeks, followed by a 4-Week Fixed Dose Period. The options for treatment are Placebo and Gabapentin, with a daily dosage of 3600 mg. The Baseline is mentioned, but no further information is provided.*
2 - image 7
This appears to be a chart showing the mean pain score across different treatment periods and doses of gabapentin. The chart shows a baseline pain score of 0 and compares the pain scores during a 3-week titration period to those during a 4-week fixed dose period. Two different doses of gabapentin (1800 mg/day and 2400 mg/day) are also compared. There is no further information provided.*
3 - image 8
4 - image 9
Label Image - lbl500903318
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.